All In Biotech

Free tool

FAERS Monitor: Clenpiq

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209589 or its brand name (Clenpiq, Citric Acid, Magnesium Oxide, Sodium Picosulfate). Reports on generic versions are filed under their own applications.

Reports

726

Serious

156

21% of reports

Hospitalization

41

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective196
  • nausea107
  • vomiting91
  • diarrhoea62
  • incorrect dose administered56
  • headache53
  • dizziness35
  • product packaging difficult to open35
  • product taste abnormal34
  • therapeutic product effect incomplete33
  • malaise32
  • abdominal distension29
  • abdominal pain upper27
  • dehydration26
  • pain23

Reports by year received

View as table
YearReports
2018100
201990
202045
202117
202289
2023134
2024118
202590
202643

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,433 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
product packaging difficult to openSignal35393.9284.413,148
product taste abnormalSignal3472.952.52,336
therapeutic product effect incompleteSignal3313.49.6369
abdominal distensionSignal298.15.6173
incorrect dose administeredSignal567.15.5291
dehydrationSignal265.63.995
vomitingSignal915.64.6348
drug ineffectiveSignal1964.33.8528
nauseaSignal1073.93.3238
abdominal pain upperSignal273.82.653
diarrhoeaSignal622.82.271
headacheSignal532.41.945
malaiseSignal322.11.518
dizzinessSignal352.01.518
pain231.10.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.